| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Medical Genetics (K. DeBella, J. Szudek, and Dr. Friedman), The University of British Columbia; and Department of Radiology (Dr. Poskitt), BC’s Children’s Hospital, Vancouver, British Columbia, Canada.
Address correspondence and reprint requests to J. Szudek, UBC Department of Medical Genetics, #222-6174 University Boulevard, Vancouver, BC, Canada V6T 1Z3.
BACKGROUND: "Unidentified bright objects" (UBOs) have been observed as areas of increased T2-weighted signal intensity on MRI in 43% to 93% of children with neurofibromatosis 1 (NF1). Because of this high frequency and the fact that the NIH diagnostic criteria often do not permit diagnosis of NF1 in early childhood, UBOs have been proposed as an additional diagnostic criterion.
METHODS: The authors examined the sensitivity and specificity of UBOs for NF1 in 19 affected children and 19 age-matched controls. Eleven of the control patients had CNS pathology that might be classified as UBOs on MRI scan. The authors measured the agreement in recognition of UBOs between two pediatric neuroradiologists who independently examined the MRI studies of these patients. They also assessed the effect of adding UBOs to the NIH diagnostic criteria on ability to diagnose NF1 in young patients.
RESULTS: Sensitivity and specificity of UBOs for NF1 averaged 97% and 79%, respectively. Agreement between the two radiologists was 84% overall, but varied greatly from one brain region to another. Adding UBOs as a diagnostic criterion permitted the diagnosis of 30% of young patients with NF1 mutations who do not meet the existing NIH diagnostic criteria for NF1. The value of including UBOs is less in older patients because a larger proportion of them meet the existing diagnostic criteria.
CONCLUSIONS: UBOs are difficult to identify with certainty and occur in children with suspected CNS disorders who do not have NF1, but they tend to occur in different brain regions. UBOs may be more useful for diagnosis of NF1 in young children if they can be defined precisely and if only the cerebellum, brainstem, and basal ganglia are considered.
Key words: Neurofibromatosis 1—Unidentified bright objects—Diagnosis—MRI.
This article has been cited by other articles:
|
|
 |
|
  L. Margari, A. Presicci, P. Ventura, S. M. Bacca, G. Iliceto, N. Medicamento, M. Buttiglione, and T. Perniola Clinical and Instrumental (Magnetic Resonance Imaging [MRI] and Multimodal Evoked Potentials) Follow-Up of Brain Lesions in Three Young Patients With Neurofibromatosis 1 J Child Neurol, December 1, 2006; 21(12): 1085 - 1090. [Abstract] [PDF]
|
|
|
|
|
|
A. G. Lasker, M. B. Denckla, and D. S. Zee Ocular Motor Behavior of Children With Neurofibromatosis 1 J Child Neurol, May 1, 2003; 18(5): 348 - 355. [Abstract] [PDF]
|
|
|
|
|
|
J.M. Friedman Review Article : Neurofibromatosis 1: Clinical Manifestations and Diagnostic Criteria J Child Neurol, August 1, 2002; 17(8): 548 - 554. [Abstract] [PDF]
|
|
|
|
 |
|
 J.-S. Guillamo, A. Creange, C. Kalifa, J. Grill, D. Rodriguez, F. Doz, S. Barbarot, M. Zerah, M. Sanson, S. Bastuji-Garin, et al. Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): A retrospective study of 104 patients Brain, January 1, 2002; 126(1): 152 - 160. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Korf Malignancy in Neurofibromatosis Type 1 Oncologist, December 1, 2000; 5(6): 477 - 485. [Abstract] [Full Text]
|
|
|
|
 |
|
 R. G. Curless, J. M. Friedman, and J. Szudek Use of ""unidentified bright objects"" on MRI for diagnosis of neurofibromatosis 1 in children Neurology, October 10, 2000; 55(7): 1067 - 1068. [Full Text] [PDF]
|
|
|
|
 |
|
 Are 'Unidentified Bright Objects' Useful for Diagnosis of Pediatric NF1? Journal Watch Neurology, August 1, 2000; 2000(801): 8 - 8. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
